Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements

Neurology. 2005 Nov 8;65(9):1506-7. doi: 10.1212/01.wnl.0000183146.78892.3f.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Akinetic Mutism / drug therapy
  • Akinetic Mutism / etiology
  • Akinetic Mutism / physiopathology
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / adverse effects
  • Chronobiology Disorders / drug therapy
  • Chronobiology Disorders / etiology
  • Chronobiology Disorders / physiopathology
  • Dopamine Agents / administration & dosage*
  • Dopamine Agents / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Administration Routes
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Drug Tolerance / physiology
  • Duodenum / physiology
  • Humans
  • Infusion Pumps
  • Levodopa / administration & dosage*
  • Levodopa / adverse effects
  • Male
  • Middle Aged
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology*
  • Retrospective Studies
  • Sleep Wake Disorders / drug therapy
  • Sleep Wake Disorders / etiology
  • Sleep Wake Disorders / physiopathology
  • Time
  • Time Factors
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Dopamine Agents
  • Levodopa